临床试验/NCT00949611

NCT00949611已完成不适用

Wiser Choices In Osteoporosis Choice II

Mayo Clinic3 个研究点分布在 1 个国家目标入组 79 人开始时间: 2009年5月最近更新: 2016年2月2日

适应症

试验速览

阶段: 不适用
状态: 已完成
发起方: Mayo Clinic
入组人数: 79
试验地点: 3
主要终点: Medication start/stop, knowledge, and patient involvement.

研究概览研究设计入排标准结局指标研究者研究点记录与标识符相似试验

研究概览

简要总结

Emphasis in treating osteoporosis has been on T-scores rather than overall fracture risk. Fracture Risk Assessment Tool (FRAX) supports a risk sensitive approach to osteoporosis treatment by providing an absolute fracture risk. FRAX combined with a decision aid may promote a shared decision making approach with patients, allowing the clinician and patient to weigh potential fracture risk (without treatment), versus risk reduction with medication (including side effects and costs). OSTEOPOROSIS CHOICE II will test the effectiveness of:

FRAX
FRAX + decision aid
Usual care (no decision aid and no FRAX given to clinician)

研究设计

研究类型: Interventional
分配方式: Randomized
干预模型: Parallel
主要目的: Supportive Care
盲法: Single (Participant)

入排标准

年龄范围: 50 Years 至 90 Years（Adult, Older Adult）
性别: Female
接受健康志愿者: 是

入选标准

•Peri and Postmenopausal Caucasian, Black, Hispanic and Asian women, aged 50-90
•Bone mineral density (BMD) T-Score < 1.0
•Have appointment with clinician to discuss test results and treatment options
•Patients with FRAX <20% risk who have taken a bisphosphonate for < 5 years.

排除标准

•Unable to speak or read English

结局指标

主要结局

Medication start/stop, knowledge, and patient involvement.

时间窗: Baseline and at 6 months

次要结局

Decisional quality.(Baseline and at 6 months)

研究者

发起方

Mayo Clinic

申办方类型

Other

责任方

Principal Investigator

主要研究者

Victor Montori

Mayo Clinic

研究点 (3)

Loading locations...

相似试验

招募中

不适用

OsteoPorotic fracTure preventION System (OPTIONS) Research StudyLower Limb FractureOsteoporosis

NCT06731608Brigham and Women's Hospital1,344

尚未招募

不适用

Optimizing osteoporosis treatment outcomes: shared-decision making and adherence support programOsteoporosis

NL-OMON22858Maastricht University Medical Centre Maastricht (Netherlands). Viecuri Medical Centre, Venlo (Netherlands).210

已完成

不适用

Concurrent Treatment of Osteoporosis for Prevention of Vertebral Fracture in Japan - Multi-center Randomized Trial with Arendoronate and alfa-calcidolOsteoporosis

JPRN-C000000001Japan Osteoporosis Society/ A-TOP consortium2,164

尚未招募

Unknown

Assessment of risk of osteoporotic fractures based on fracture risk assessment tool

CTRI/2024/03/064702Rohilkhand medical college and hospital

Unknown

1 期

Nasally and sc Administered Teriparatide in Healthy VolunteersOsteoporosis

NCT01913834Nottingham University Hospitals NHS Trust7